Telegram Notes

Brittany Kaiser Is a TON

Note: This is another post about the Telegram-centric AlphaTON Capital publicly-traded company. This collection of notes from my research about Cambridge Analytica, a quite controversial social media company, and what I have been capturing since I became interested in the Red Shark, Yuri Mitin, whom I describe as the Russian Tony Robbins. In my "The Telegram Labyrinth" I skip over the separate companies that seem to be "orchestrated" by the TON Foundation but actually operate to enhance the Pavel Durov-owned Telegram operation. Remember, the statements in this essay are from my notes and should be viewed as working hypotheses and open research questions. Verify before you trust any of my observations. I use these Telegram Notes' posts to capture my ideas for myself, the members of my team, and individuals who are intrigued by the Telegram "machine." Keep these disclaimers in mind as you review this briefing document.

Along for the Ride?

Edward Moll, my high school biology teacher, yapped about sharks. I remember his explanation of a remora or what Mr. Moll called "suckerfish." My memory is rusty because Mr. Moll shared his shark love with us in 1958. The idea is, I think, commensalism. The shark (the host) lets the suckerfish feast on microbes and parasites; the remora snags a free ride.

The question is, "What type of suckerfish does a red shark attract?" I have an answer, and it may not be the correct one. My notes say, "Yuri Mitin is the 'red shark' in the re-branded RSV Ventures. The remora may be Dr. Brittany Kaiser, the CEO of AlphaTON Capital, a whistle blower, and a social media expert with a Ph.D." Her expertise? Preventive diplomacy and data-driven early-warning systems.

What has been doing since she answered questions before the British Parliament about Cambridge Analytica, SCL, and tactical information shaping. I had some notes from a project related to the Cambridge Analytica operation. These reminded me that I had met Alexander Nix, president of Cambridge Analytica at an information conference. He was quite sure of himself. I jotted down, "SCL and Cambridge Analytics pitched information shaping to the Russian enterprise Lukoil. Dr. Kaiser ... involved in some of those Lukoil interactions?"

I knew Dr. Kaiser was positioned as a business development professional with social media analytics know how. When Cambridge Analytica found itself on the wrong side of an investigation conducted by British authorities, Dr. Kaiser became a cooperative witness. From my notecards: "She flipped, talked, and walked."

By the time the Cambridge Analytica inquiry ended in 2019, she had returned to the United States from the UK. Before she completed her Ph.D., she was involved in American politics. She worked on Barack Obama's presidential campaign. Some of the volunteer workers and compensated staff members were social media adepts and apparently more adept than John McCain's social media team.

After Cambridge Analytica-gate

Once back in the US in 2018, she moved through a range of volunteer work, board memberships, and start ups. The table below provides a reasonably complete summary of her work experience.

Dr. Brittany Kaiser, Post 2018 Engagements

In August 2025, she became the chief executive officer of AlphaTON Capital. In about four months, the company moved from a deal to acquire the shell of a distressed publicly-traded company to the publicly-listed AlphaTON Capital entity trading on NASDAQ. (Notecard to myself: Who hired Dr. Kaiser? Was it Yuri Mitin, the founder of Red Shark Ventures? Was it some other person, holding company, or group?)

What's her track record in that period from August 2025 to the end of January 2026? Here's a rundown of achievements or actions in this time period:

  1. In September 2025, Dr. Kaiser, the NASDAQ expert (Enzo Villani), and Yuri Mitin performed a shelf registration (aka “baby shelf”). Announcements reported capital raising to enable the rapid issuance of shares. Purpose: Raise money. This activity resulted in some SEC scrutiny of the firm.

  2. She participated in the planning of the termination of AlphaTON Capital's deal with DWF Maas and Andrei Grachev, an Uzbeki who is market maker and president of a high-frequency trading company specializing in crypto tokens. (Mr. Grachev served for several years on Russia's RACIB (Russian Association of Cryptoeconomics, Artificial Intelligence and Blockchain, which "organized" crypto innovations and support.)

  3. In November 2025, Dr. Kaiser participated in recruiting Wes Levitt as chief financial officer, possibly to replace Mr. Grachev who collected a payment to leave AlphaTON Capital.

  4. In November 2025, a chief technology officer was recruited. Logan Ryan Golema joined AlphaTON Capital as its CTO. He would be responsible for the AI data center activity and provide the company with blockchain leadership. He does have experience as an eGamer. He does not have appear to have substantive experience managing a decentralized, distributed AI mining system.

  5. On Nov 5, 2025, AlphaTON announced its intent to purchase acquire Blockchain Wire, a crypto and blockchain press-release distribution service. A few weeks later, AlphaTON Capital submitted a Letter of Intent (LOI) to acquire a controlling stake in Forbes Media Holdings. The idea was that AlphaTON Capital would have access to a "name brand" in order to combine legacy-type news with crypto information. [Note: This media play seems like a search engine optimization tactic. AlphaTON Capital (the company name) is linked to Forbes. The content from AlphaTON Capital gets pushed out via Forbes and the Blockchain outlet. The objective was to enhance the credibility to the AlphaTON Capital "brand." On my notecard, I wrote: "The approach reminds me of what I learned reading the documents released by the British government about the Cambridge Analytica / SCL inquiry."

  6. In December 2025, AlphaTON Capital announced its deal with the high-flying, high-technology outfit Anduril Industries. AlphaTON issued a press release claiming a “historic strategic $30 million investment” in Anduril, saying it had acquired Anduril equity into its treasury and planned a $100 million tokenized fund via a Telegram mini-app to continue accumulation. Within a day, Anduril’s CEO publicly denied AlphaTON Capital's claim. This direct denial caused a significant market reaction, including a sharp drop in ATON’s stock. AlphaTON Capital issued a statement trying to patch its misstep with spackle and spray paint.

  7. Then, in December 2025, AlphaTON Capital initially issued a press release saying it had an equity line financing with ATW Partners, LLC for approximately $18.5 million. That company would allegedly provide capital for Dr. Kaiser's company. AlphaTON Capital then retracted that claim, clarifying that “AlphaTON Capital has No Equity Line Financing with ATW Partners or any other provider. ATW Partners is not an investor”, and that there was no current agreement, commitment, or intention by ATW to invest in the company.

Observations

Let me offer several high-level observations.

First, the misstatements about Andurill Technologies suggest poor judgment or an assumption that facts don't matter for PR campaigns. Enzo Villani was a senior manager at NASDAQ. Either he did not catch these material misstatements or he was not in the loop. The fact that fabrications had an impact on the credibility of the AlphaTON Capital operation and the firm's stock price. In either case, AlphaTON Capital's leadership did not buttoned up.

Second, the senior management game of musical chairs suggests instability in the organization. A new CFO and a new law firm joined the team reporting to Dr. Kaiser. To make organizational space for the CFO, the deal with DWF MaaS was terminated at a cost of about $15 million. Andrei Grachev had made advance preparations. He left the company and applied his talents to his Falcon Finance venture.

Third, Dr. Kaiser appears to have an objective in mind: Use "news" to increase the awareness of AlphaTON Capital. As CEO of a publicly-traded firm, her management methods seem to be somewhat negative.

My view is that Dr. Kaiser's behavior is different from what I have encountered among CEOs. For many years, I was the "right hand" of the president of a blue-chip consulting firm. I worked for the president of a major French technology company. I served a member of Congress who was a four star admiral. In those roles, the management style was to stabilize, not fabricate and reduce the value of the organizations. Each of these leaders with whom I worked focused on achievable goals, ethical behavior, and consistent, repeatable business processes. AlphaTON Capital's CEO is operating in a manner unfamiliar to me.

Here is a question: How long will the remora be able hang on to the red shark?

Stephen E Arnold, February 15, 2026